Using a newly developed potent TRPC6 antagonist, a separate study also showed that inhibition of this Ca2+ channel suppresses proliferation of several GC cell lines as well as GC tumor growth in a xenograft model (Ding et al., 2018). This evidence concerns the gene TRPC6 and gastric cancer.